Inhibition of Bleomycin-Induced Toxic Effects by Antioxidants in Human Malignant Melanoma Cells
Bleomycin is an antibiotic drug used in tumor chemotherapy. It forms a complex with iron ions which can be reduced chemically or enzymatically. The bleoraycin-Fe(II)-complex binds and activates oxygen and degrades cellular DNA. This activity of bleomycin is presumably responsible for the cytotoxic effects observed during therapy (for reviews see Burger et al., 1981; Hecht, 1986). Because reactive oxygen species are involved, we wondered whether antioxidants could inhibit bleomycin-induced cytotoxicity. For example, the seleno-organic compound Ebselen (2-pheny1–1,3-benzisoselenazo1–3(2H)one) has besides its glutathione peroxidase-like activities also antioxidant properties (Müller et al., 1984). It inhibits cell toxicity induced by adriamycin (Doroshow, 1986) and diquat (Cotgreave et al., 1987), both redox cycling compounds which can induce formation of reactive oxygen species. The other antioxidants examined were pyrogallol and propyl gallate which have also been shown to trap reactive oxygen species (Weinke et al., 1987).
KeywordsHuman Malignant Melanoma Cell Redox Cycling Propyl Gallate Significant Toxic Effect Strand Scission
Unable to display preview. Download preview PDF.
- Burger, R.M., Peisach, J., and Horwitz, S.B., 1981, Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA, J. Biol. Chem. 256:11636Google Scholar
- Kappus, H., Mahmutoglu, I., Kostrucha, J., and Scheulen, M.E., 1987, Liver nuclear NADPH-cytochrome P-450 reductase may be involved in redox cycling of bleomycin-Fe(III), oxy radical formation and DNA damage, Free Rad. Res. Comms. 2:271Google Scholar
- Müller, A., Cadenas, E., Graf, P., and Sies, H., 1984, A novel biologically active seleno-organic compound I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ5l (Ebselen). Biochem. Pharmacol. 33:3235Google Scholar